Figure 3.
SARS-CoV-2 replication and spread in type I interferon-negative ATII pneumocytes. A, Red cells are viral RNA+; green cells are napsin A+ ATII cells; red-green cells are infected ATII cells; nuclei stained blue with DAPI. The viral RNA+ ATII cells in numbered regions 1–5 are spatially contiguous, consistent with spread of infection to susceptible type II cells in close spatial proximity. Region 6 shows a napsin A− viral RNA+ cell overlying lysed viral RNA+ epithelial syncytium. Region 7 shows a viral RNA+ napsin A+ and napsin A− cell conjugate, consistent with acquisition of viral RNA in macrophages by phagocytosis. B, SARS-CoV-2 virions and intracellular RNA, green. Virus spread and fusion of spatially contiguous ATII cells generates focal clusters of virus-producing cells. C, SARS-CoV-2 RNA+ cells, red; type I interferon, green; nuclei stained blue with DAPI. Viral RNA+ cells are type I interferon−, and interferon+ cells are viral RNA−. Abbreviations: AT, alveolar type; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

SARS-CoV-2 replication and spread in type I interferon-negative ATII pneumocytes. A, Red cells are viral RNA+; green cells are napsin A+ ATII cells; red-green cells are infected ATII cells; nuclei stained blue with DAPI. The viral RNA+ ATII cells in numbered regions 1–5 are spatially contiguous, consistent with spread of infection to susceptible type II cells in close spatial proximity. Region 6 shows a napsin A viral RNA+ cell overlying lysed viral RNA+ epithelial syncytium. Region 7 shows a viral RNA+ napsin A+ and napsin A cell conjugate, consistent with acquisition of viral RNA in macrophages by phagocytosis. B, SARS-CoV-2 virions and intracellular RNA, green. Virus spread and fusion of spatially contiguous ATII cells generates focal clusters of virus-producing cells. C, SARS-CoV-2 RNA+ cells, red; type I interferon, green; nuclei stained blue with DAPI. Viral RNA+ cells are type I interferon, and interferon+ cells are viral RNA. Abbreviations: AT, alveolar type; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close